<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04567212</url>
  </required_header>
  <id_info>
    <org_study_id>SNPS asthma</org_study_id>
    <nct_id>NCT04567212</nct_id>
  </id_info>
  <brief_title>Gender Differences and SNPs in Asthmatic Patients</brief_title>
  <official_title>Gender Differences and SNPs in Asthmatic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Catanzaro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Azienda Sanitaria Provinciale Di Catanzaro</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Azienda Ospedaliera Universitaria Mater Domini, Catanzaro</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Catanzaro</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The GINA 2020 guidelines suggest that asthma affects approximately 300 million persons&#xD;
      worldwide. Even if there is a specific drug treatment for each stage of disease (From mild to&#xD;
      severe) in some patients it is not efficacy and it culd be reated to the gender difference&#xD;
      Polymorphisms seems to be involved in asthma (allergic or not) even if no data have been&#xD;
      published concerning the role of gender in this clinical manifestation. The aim of this study&#xD;
      is to assess whether genetic variations involved in the genes encoding the two key&#xD;
      leukotriene enzymes, ALOX5 and LTC4S, and CysLTR1 are implicated in the sex difference of&#xD;
      allergic asthma in a well-characterized patient cohort.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The GINA 2020 guidelines suggest that asthma affects approximately 300 million persons&#xD;
      worldwide. Even if there is a specific drug treatment for each stage of disease (From mild to&#xD;
      severe) in some patients it is not efficacy and it culd be reated to the gender difference&#xD;
      Polymorphisms seems to be involved in asthma (allergic or not) even if no data have been&#xD;
      published concerning the role of gender in this clinical manifestation. The role of&#xD;
      polymorphisms in susceptibility to allergic asthma has been partially investigated but no&#xD;
      study has analysed gender subgroups separately, neglecting a their potential predictive role&#xD;
      in symptomatological and functional variations in the allergic asthma in both sexes. The aim&#xD;
      of this study is to assess whether genetic variations involved in the genes encoding the two&#xD;
      key leukotriene enzymes, ALOX5 and LTC4S, and CysLTR1 are implicated in the sex difference of&#xD;
      allergic asthma in a well-characterized patient cohort.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2020</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 20, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Expression of SNPs</measure>
    <time_frame>1 month</time_frame>
    <description>statistically significant difference (P&lt;0.05) in SNPs expression between male and female</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Concentration of MicroRNA</measure>
    <time_frame>1 month</time_frame>
    <description>statistically significant difference (P&lt;0.05) in microRNA between male and female</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SNPs and age</measure>
    <time_frame>1 month</time_frame>
    <description>statistically significant difference (P&lt;0.05) in SNPs expression between age &gt; 12 years and &lt; 12 years</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Allergic Asthma</condition>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Male-group</arm_group_label>
    <description>in this group we will enroll only male with asthma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Female-group</arm_group_label>
    <description>in this group we will enroll only female with asthma</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>genetic evaluation</intervention_name>
    <description>A sampe of blood (3 mL) and of oral mucosa will be take and analyzed using nCounter GX Human Inflammation Kit a comprehensive number of 8SNPs in 3 human genes known to be differentially expressed in allergic asthma.</description>
    <arm_group_label>Female-group</arm_group_label>
    <arm_group_label>Male-group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MicroRNA evaluation</intervention_name>
    <description>Using the sampe of blood (3 mL) using RT-PCR we will evaluate the expression of microRNA in enrolled patients</description>
    <arm_group_label>Female-group</arm_group_label>
    <arm_group_label>Male-group</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      we will take the oral swab in order to evaluate the enzyme expression&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        We will perform an observational study in patients with asthma enrolled fro general&#xD;
        practitioners and specialist in respiratory disease. After the recruitment a sample of&#xD;
        blood and oral mucosa will be taken to evaluate the expression of SNPs and of inflammatory&#xD;
        status&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  asthma (allergic or not) diagnosed according to Global Initiative for Asthma&#xD;
             guidelines (GINA 2020).&#xD;
&#xD;
          -  signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  â€¢ infectious diseases&#xD;
&#xD;
               -  neurodegenerative diseases&#xD;
&#xD;
               -  autoimmune diseases&#xD;
&#xD;
               -  neoplasms&#xD;
&#xD;
               -  progressive serious medical conditions (such as cancer, AIDS or end-stage renal&#xD;
                  disease)&#xD;
&#xD;
               -  alcohol consumption (&gt;3 alcoholic beverages daily)&#xD;
&#xD;
               -  substanceabuse&#xD;
&#xD;
               -  inability to give written informed consent&#xD;
&#xD;
               -  those who will not sign the consent to the processing of personal data&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>AO Materdomini</name>
      <address>
        <city>Catanzaro</city>
        <state>Italia</state>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luca Gallelli, MD</last_name>
      <phone>+390961712537</phone>
      <email>gallelli@unicz.it</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>ASP Catanzaro</name>
      <address>
        <city>Catanzaro</city>
        <zip>88100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio Guerra, MD</last_name>
      <phone>3398199190</phone>
      <email>guerra.antonio@simg.it</email>
    </contact>
    <investigator>
      <last_name>Antonio Scuteri, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Giacomo Leuzzi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Giuseppe Giuliano, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>September 11, 2020</study_first_submitted>
  <study_first_submitted_qc>September 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 28, 2020</study_first_posted>
  <last_update_submitted>November 20, 2020</last_update_submitted>
  <last_update_submitted_qc>November 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Catanzaro</investigator_affiliation>
    <investigator_full_name>Luca Gallelli</investigator_full_name>
    <investigator_title>MD PhD</investigator_title>
  </responsible_party>
  <keyword>asthma</keyword>
  <keyword>allergy</keyword>
  <keyword>Gender</keyword>
  <keyword>polymorphism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

